Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis

被引:0
|
作者
Dobrota, Rucsandra [1 ]
Maurer, Britta [2 ]
Graf, Nicole [3 ]
Mihai, Carina [1 ]
Kiwal-Bielecka, Otylia [4 ]
Allanore, Yannick [5 ,6 ]
Distler, Oliver [2 ]
机构
[1] Carol Davila Univ Med & Pharm, Dr I Cantacuzino Hosp, Dept Internal Med & Rheumatol, Bucharest, Romania
[2] Univ Zurich Hosp, Div Rheumatol, CH-8091 Zurich, Switzerland
[3] Graf Biostat, Winterthur, Switzerland
[4] Med Univ Bialystok, Dept Rheumatol & Internal Med, Bialystok, Poland
[5] Univ Paris 05, Dept Rheumatol, Paris, France
[6] Cochin Hosp, Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
722
引用
收藏
页码:S315 / S315
页数:1
相关论文
共 50 条
  • [1] Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
    Dobrota, Rucsandra
    Maurer, Britta
    Graf, Nicole
    Jordan, Suzana
    Mihai, Carina
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) : 1743 - 1748
  • [2] PREDICTION OF IMPROVEMENT IN SKIN FIBROSIS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS - A EUSTAR ANALYSIS
    Dobrota, R.
    Maurer, B.
    Graf, N.
    Mihai, C.
    Kowal-Bielecka, O.
    Allanore, Y.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 819 - 819
  • [3] Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis - a EUSTAR analysis
    Dobrota, Rucsandra
    Maurer, Britta
    Graf, Nicole
    Mihai, Carina
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    SWISS MEDICAL WEEKLY, 2015, 145 : 2S - 2S
  • [4] Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
    Maurer, Britta
    Graf, Nicole
    Michel, Beat A.
    Mueller-Ladner, Ulf
    Czirjak, Laszlo
    Denton, Christopher P.
    Tyndall, Alan
    Metzig, Carola
    Lanius, Vivian
    Khanna, Dinesh
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1124 - 1131
  • [5] Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis
    Ikuko Hayakawa
    Shinichi Sato
    Takeshi Echigo
    Fumiaki Shirasaki
    Minoru Hasegawa
    Kazuhiko Takehara
    Clinical Rheumatology, 2004, 23 : 345 - 347
  • [6] Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis
    Hayakawa, I
    Sato, S
    Echigo, T
    Shirasaki, F
    Hasegawa, M
    Takehara, K
    CLINICAL RHEUMATOLOGY, 2004, 23 (04) : 345 - 347
  • [7] Systemic sclerosis:: Improvement of cutaneous fibrosis on bosentan therapy
    Alegre-Sancho, JJ
    Román-Ivorra, JA
    Fernandez-Carballido, C
    Chalmeta-Verdejo, I
    Abad-Franch, L
    Alcañiz-Escandell, C
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 339 - 339
  • [8] PREDICTION OF WORSENING OF SKIN FIBROSIS IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS USING THE EULAR SCLERODERMA TRIALS AND RESEARCH (EUSTAR) REGISTRY
    Maurer, B.
    Graf, N.
    Michel, B. A.
    Khanna, D.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 498 - 499
  • [9] Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
    Hinchcliff, Monique
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1237 - 1240
  • [10] Tofacitinib as a possible treatment for skin thickening in diffuse cutaneous systemic sclerosis
    You, Hanxiao
    Xu, Dong
    Hou, Yong
    Zhou, Jiaxin
    Wang, Qian
    Li, Mengtao
    Zeng, Xiaofeng
    RHEUMATOLOGY, 2021, 60 (05) : 2472 - 2477